title: Effects of perindopril on carbohydrate and lipoprotein metabolism in essential hypertension.
abstract: Fourteen outpatients with mild-to-moderate essential hypertension were treated with perindopril (4-8 mg once daily) for a 16-week period. It was observed that the drug was effective in lowering blood pressure without inducing changes in blood lipids commonly observed with other hypotensive agents. This lipid neutrality, in addition to the lack of side or toxic effects, confers on perindopril a noteworthy therapeutic value in the treatment of essential hypertension.
authors.affiliation: Department of Internal Medicine, Hospital of Val di Nievole, Pescia, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Giuntoli
authors.forename: S
authors.initials: S
authors.lastname: Gabbani
authors.forename: A
authors.initials: A
authors.lastname: Natali
authors.forename: F
authors.initials: F
authors.lastname: Galeone
authors.forename: P
authors.initials: P
authors.lastname: Saba
mesh_terms: D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D001786:Blood Glucose / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D007211:Indoles / Q000494:pharmacology*; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D020913:Perindopril
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D001786:Blood Glucose; D007211:Indoles; D008074:Lipoproteins; D020913:Perindopril